SCHEMBL9904008

SCHEMBL9904008

Cn1c(=O)c2[nH]c(-n3cc(-c4cccc(O)c4)nn3)nc2n(C)c1=O

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.57
ADORA2B P29275 3/20 0.49
ADORA2A P29274 2/20 0.47
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
KDM4E B2RXH2 2/20 0.46
CYP1A2 P05177 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA1 P30542 1/20 0.46
BLM P54132 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
DCTPP1 Q9H773 1/20 0.46
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904312 0.88 ADORA2B (0.48) MAPTADORA2BADORA2AKDM4ECYP1A2
SCHEMBL9928557 0.86 ADORA2B (0.49) ADORA2BADORA2AKDM4ECYP1A2ADORA3
SCHEMBL9904142 0.85 ADORA2B (0.51) MAPTADORA2BADORA2AKDM4ECYP1A2
SCHEMBL9943454 0.83 ALDH1A1 (0.64) ADORA2BADORA2AKDM4ECYP1A2ADORA3
SCHEMBL9904126 0.81 DCTPP1 (0.56) ADORA2BADORA2AKDM4ECYP1A2ADORA3
SCHEMBL9904107 0.80 ADORA2B (0.46) ADORA2BADORA2AKDM4ECYP1A2ADORA3
SCHEMBL9904114 0.80 MAPT (0.57) MAPTADORA2BADORA2AKDM4ECYP1A2
SCHEMBL9928558 0.79 ADORA2A (0.43) ADORA2BADORA2AKDM4ECYP1A2ADORA3
SCHEMBL9928556 0.79 ADORA2B (0.61) MAPTADORA2BADORA2AKDM4ECYP1A2
SCHEMBL9928559 0.79 KDM4E (0.49) MAPTADORA2BADORA2AKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed